Corbion Nv · EURONEXT:CRBN

Corbion Nv — Q3 2016 Earnings Presentation

11 slides from Corbion Nv's earnings presentation, Oct 21, 2016

  1. Slide 1: Q3 2016 Results

    Q3 2016 RESULTS TJERK DE RUITER/EDDY VAN RHEDE 21/10/2016 VAN DER KLOOT

  2. Slide 2: Highlights first nine months 2016

    Highlights first nine months 2016 • Organic net sales decrease of -0.2%, volumes down (-0.8%), price/mix up (0.6%) • Net sales decrease of -0.4%; currencies -0.4% • Food: continues decline after stronger start of the year • Biochemicals: continues recovery after weaker start of the year • EBITDA exc

  3. Slide 3: Biobased Ingredients

    Biobased Ingredients YTD YTD Q3 Q3 € million 2016 2015 2016 2015 • Organic sales growth YTD: -0.8% Net Sales 667.7 674.6 223.2 229.4 Organic growth -0.8% 3.8% -3.3% 3.3% • EBITDA YTD margin increase to EBITDA excl. one-off items 137.6 119.8 45.5 39.7 20.6% (YTD 2015: 17.8%) Margin 20.6% 17.8% 20.4%

  4. Slide 4: Business Segment Food

    Business Segment Food YTD YTD Q3 Q3 Key items first nine months € million 2016 2015 2016 2015 Net Sales 507.1 518.3 170.3 179.6 • Organic sales decline of -1.8% Organic growth -1.8% 4.0% -5.8% 5.0% • Margin improvement from business mix, lower input costs and program Streamline EBITDA excl. one-off

  5. Slide 5: Business Segment Biochemicals

    Business Segment Biochemicals YTD YTD Q3 Q3 Key items first nine months € million 2016 2015 2016 2015 Net Sales 160.6 156.3 52.9 49.8 • Organic sales growth weak in Q1, Organic growth 2.4% 2.9% 5.5% -2.1% stronger in Q2 and Q3. YTD: 2.4% EBITDA excl. one-off items 41.5 35.2 13.1 11.8 • Broad based g

  6. Slide 6: Biobased Innovations

    Biobased Innovations YTD YTD Q3 Q3 Key items first nine months € million 2016 2015 2016 2015 Net Sales 17.5 13.3 6.3 6.2 • EBITDA loss in first nine months Organic growth 31.8% 78.7% 2.1% 76.5% 2016 almost equal to YTD 2015 • Higher lactide/PLA sales EBITDA excl. one-off items (2.8) (2.7) (0.5) 0.1

  7. Slide 7: Profit & Loss Statement

    Profit & Loss Statement € million YTD 2016 YTD 2015 Q3 2016 Q3 2015 Growth YTD Net sales Biobased Ingredients 667.7 674.6 223.2 229.4 -1.0% - Food 507.1 518.3 170.3 179.6 -2.2% - Biochemicals 160.6 156.3 52.9 49.8 2.8% Biobased Innovations 17.5 13.3 6.3 6.2 31.6% Total net sales 685.2 687.9 229.5 23

  8. Slide 8: Growth per Segment

    Growth per Segment Total growth Total Currency at constant Acquisitions Organic Price/Mix Volume growth currency YTD 2016 vs 2015 Biobased Ingredients -1.0% -0.4% -0.6% 0.2% -0.8% 1.2% -2.0% - Food -2.2% -0.6% -1.6% 0.2% -1.8% 1.4% -3.2% - Biochemicals 2.8% 0.2% 2.6% 0.2% 2.4% -0.2% 2.6% Biobased In

  9. Slide 9: EBITDA bridge YTD 2016

    EBITDA bridge YTD 2016 160 • Organic growth mostly driven by pricing and mix 140 24.9 3.8 -4.6 -1.8 0.0 • Main price/mix components: -2.3 120 • Lower input costs -2.0 100 • Business mix improvement Biobased Ingredients 134.8 in Food and Biochemicals 130.4 80 117.1 • Cost level including general infl

  10. Slide 10: EBITDA bridge Q3 2016

    EBITDA bridge Q3 2016 50 1.4 0.0 45 1.2 7.0 -0.6 -2.1 40 35 -3.9 30 25 45.0 Biobased Ingredients 42.9 20 39.8 15 10 5 0 10 © 10/20/2016

  11. Slide 11: Corbion

    ? Corbion

Corbion — Q3 2016 Earnings Presentation on 6ix